The Journal of Pharmaceutical Policy and Practice is the official journal of the Commonwealth Pharmacists Association.
Articles
Page 5 of 14
-
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:75
-
Public and decision-maker stated preferences for pharmaceutical subsidy decisions in Iran: an application of the discrete choice experiment
The argument about funding criteria poses challenges for health decision-makers in all countries. This study aimed to investigate the public and decision-maker preferences for pharmaceutical subsidy decisions ...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:74 -
UK and Ireland survey of MPharm student and staff experiences of mental health curricula, with a focus on Mental Health First Aid
One in four people experience a mental health problem every year and improving mental health care is an international priority. In the course of their work, pharmacists frequently encounter people with mental ...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:73 -
Regulatory compliance among over-the-counter medicine sellers facilities within the Upper East Region of Ghana
Easy access to medicines provided by private medicine retailing facilities including that of over-the-counter medicine retailers, have gained prominence in sub-Saharan Africa. Although over-the-counter medicin...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:72 -
Assessment of job satisfaction among pharmacy professionals
Job satisfaction of pharmacy professionals is appreciably related to quality of pharmaceutical care. Poor Job satisfaction is associated with low productivity, absenteeism, high turnover and reduced working ho...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:71 -
Engagement of hospital pharmacists and technicians to optimize staffing schedules
Challenges exist in developing work schedules for hospital pharmacy staff due to the need to meet around the clock patient care requirements. Work–life integration and reduced burnout are increasingly importan...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:70 -
Access, use and disposal of antimicrobials among humans and animals in Wakiso district, Uganda: a qualitative study
Inappropriate use of antimicrobials in both humans and animals is a key driver of antimicrobial resistance (AMR). In addition, human behaviours such as poor disposal of antimicrobials in the environment can in...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:69 -
Recommendations to improve pharmacy practice research in the Middle Eastern Arab countries
The expansion of the pharmacist-led services has resulted in increased demand to have evidence in terms of necessity, efficacy, and cost. Evidence-based practice is crucial to provide the best patient health o...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:68 -
Diabetes, hypertension and dyslipidemia medication prescribing in Qatari primary care settings: a retrospective analysis of electronic medical records
Globally, non-communicable diseases (NCDs) are recognised as a leading cause of morbidity and mortality. Medications and medicines optimisation play an important role in the management of modifiable physiologi...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:67 -
Young hospital pharmacists’ job stress and career prospects amidst the COVID-19 pandemic in China
Coronavirus disease (COVID-19) pandemic posed a critical threat to public health in the past year and has not been fully controlled so far. The nature of front-line young hospital pharmacists’ occupation puts ...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:66 -
Analysis of intracranial haemorrhage following tozinameran (BNT162b2, Pfizer-BioNTech)
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:65 -
Investigating the effect of pharmaceutical logistics service performance on customer satisfaction: a two-step approach with structural equation modeling
These days, pharmaceutical customers are the utmost stakeholders in the healthcare supply chain, and ensuring their satisfaction with the logistics services has become worthwhile. This study aimed to investiga...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:64 -
Potential drug–drug interactions in patients with cardiovascular diseases: findings from a prospective observational study
Patients with cardiovascular diseases (CVD) are at high risk of experiencing drug–drug interactions (DDIs). The objective of this study was to evaluate the frequency, level and risk factors associated with pot...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:63 -
Stakeholders’ perspectives on training over the counter medicine sellers and Community-based Health Planning and Services facilities to dispense antibiotics in Ghana
Dispensing of antibiotics by over the counter medicine sellers (OTCMS) is a major driver of inappropriate use and resistance in low and middle income countries. Recent studies in Ghana revealed the need to con...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:62 -
Pharmacy preparedness in handling COVID-19 pandemic: a sharing experience from a Malaysian tertiary hospital
This commentary shares the experience of a hospital pharmacy department in providing healthcare services during the COVID-19 outbreak in Malaysia. During this pandemic, the medication delivery system is redesi...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:61 -
“Drugs to avoid” to improve quality use of medicines: how is Australia faring?
Each year, the French independent bulletin Prescrire publishes a list of medicines, “Drugs to avoid”, that should not be used in clinical practice as their risk-to-benefit ratio is unfavourable. This study assess...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:60 -
Eliciting the public preferences for pharmaceutical subsidy in Iran: a discrete choice experiment study
Deciding on pharmaceutical subsidy is regarded as a challenging issue for healthcare policymakers in Iran in most times. Public preferences, rarely attended in Iran, could be invaluable for including a particu...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:59 -
Health professionals’ perception of pharmaceuticals procurement performance in public health facilities in Southwestern Ethiopia
Pharmaceutical’s procurement is a core component of logistics management, and has a significant influence on product availability, and total supply chain costs. In Ethiopia, there are few studies on this topic...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:58 -
Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology
Access to essential medicines is a universal human right and availability and affordability are the preconditions for it. In line with the sustainable development goals, World Health Organization (WHO) has out...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:57 -
Strategies to improve pharmaceutical supply chain resilience under politico-economic sanctions: the case of Iran
Given the impact of politico-economic sanctions on the pharmaceutical supply chain, this study aims to identify practical strategies to improve the resilience of the Iranian supply chain in pharmaceutical proc...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:56 -
Medication adherence among the elderly: applying grounded theory approach in a developing country
Medication adherence is an important concept particularly among the elderly that can, directly and indirectly, affect the health system’s costs and the elderly’s health, quality of life, and functional abiliti...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:55 -
Evaluation of pharmacy-led weight management service to minimise the risk of cardiovascular disease
The primary aim of the programme was a minimum of a 5% weight reduction of the initial weight, while the secondary outcomes were a reduction in participants’ body mass index (BMI), waist circumference (WC), bl...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:54 -
Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians
With the approval of biosimilars for subcutaneously administered products, such as adalimumab, etanercept and insulin, biosimilars become increasingly available in ambulatory care. Little is known about the kn...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:53 -
Case studies for implementing MCDA for tender and purchasing decisions in hospitals in Indonesia and Thailand
A multi-criteria decision analysis (MCDA) approach has been suggested for helping purchasers in low- and middle-income countries in an evidence-based assessment of multi-source pharmaceuticals to mitigate pote...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:52 -
A cross-sectional survey on community pharmacists readiness to fight COVID-19 in a developing country: knowledge, attitude, and practice in Lebanon
Lebanon, a developing Middle Eastern country, was hit by the COVID-19 pandemic that occurred amid a severe national economic crisis. Community pharmacists are responsible for dispensing appropriate medications...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:51 -
Identification and resolution of drug-related problems among diabetic patients attending a referral hospital: a prospective observational study
People living with diabetes are more vulnerable to drug-related problems due to the presence of multiple diseases. This study aimed to identify drug-related problems and contributing factors among diabetic pat...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:50 -
Prevalence, knowledge and perception of self-medication practice among undergraduate healthcare students
Globally, self-medication is a common practice, and an increasingly perceived necessity to relieve burdens on health services. However, inappropriate self-medication may result to reduced health outcomes, incr...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:49 -
Big data, medicines safety and pharmacovigilance
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:48 -
Pharmacoeconomics in Africa: needs, prospect and challenges
Africa as a continent has experienced a continuous increase in the cost of healthcare as its demands increase. With many of these African countries living below the poverty threshold, Africans continue to die ...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:47 -
Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)
Reports of cerebral venous sinus thrombosis and intracranial hemorrhage (ICH) following the administration of coronavirus vaccines have raised concerns regarding their safety. Although no regulatory authority ...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:46 -
National drug utilization trend of analgesics in China: an analysis of procurement data at 793 public hospitals from 2013 to 2018
This research aimed to evaluate analgesic utilization in public hospitals from 2013 to 2018 by analyzing the procurement data of 793 hospitals in China.
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:45 -
Correction to: Online medication purchasing during the Covid-19 pandemic: a pilot study from the United Arab Emirates
An amendment to this paper has been published and can be accessed via the original article.
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:44 -
Assessments of the quality systems of pharmaceutical distributors: a remote approach to be applied in times of COVID-19 and beyond
Adequate quality systems throughout pharmaceutical supply chains are crucial to protect individuals and communities from substandard and falsified medical products. Thus, pharmaceutical distributors are regula...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:43 -
Cardiovascular disease risk prevention services by pharmacists in Saudi Arabia: what do policymakers and opinion leaders think?
Cardiovascular disease (CVD) is an emerging contributor to national morbidity and mortality in Saudi Arabia. CVD risk prevention services are limited, particularly with an over-utilised public health sector an...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:42 -
The implementation of pharmaceutical services in public hospitals in Mexico: an analysis of the legal framework and organizational practice
The implementation of pharmaceutical services in hospitals contributes to the appropriate use of medicines and patient safety. However, the relationship of implementation with the legal framework and organizat...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:41 -
Public and private sectors collective response to combat COVID-19 in Malaysia
Over the last year, the dangerous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly around the world. Malaysia has not been excluded from this COVID-19 pandemic. The resurgence of...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:40 -
Adequacy of alcohol-based handrub solution production practice in response to COVID-19 in public hospitals found in Addis Ababa, Ethiopia: a multicentered cross-sectional study
Proper hand hygiene using alcohol-based handrub (ABHR) is an effective preventive approach for the current Coronavirus Disease 2019 (COVID-19) pandemic and other infections. World Health Organization recommend...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:39 -
Online medication purchasing during the Covid-19 pandemic: A pilot study from the United Arab Emirates
Since the WHO announced that Covid-19 had become a global pandemic, online pharmacies have emerged as an extremely popular way to purchase medication due to the quarantine measures introduced by numerous count...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:38 -
EU FP7 research funding for an orphan drug (Orfadin®) and vaccine (Hep C) development: a success and a failure?
We considered the extent of the contribution of publicly funded research to the late-stage clinical development of pharmaceuticals and medicinal products, based on the European Commission (EC) FP7 research fun...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:37 -
Drug-related problems and associated factors in Ethiopia: a systematic review and meta-analysis
Drug-related problems (DRPs) can occur at any stages of medication use processes, and a single drug could be associated with multiple DRPs. Once happened, it adversely affects health outcomes. In Ethiopia, eva...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:36 -
Differences in glycemic control between the treatment arms in cardiovascular outcome trials of type 2 diabetes medications do not explain cardiovascular benefits
Hyperglycemia is an undisputed epidemiological risk factor for microvascular complications in both type 1 and type 2 diabetes, integral in their causal pathways. Importantly, interventions that reduce the hype...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:35 -
Towards improving community pharmacy-based mental health services in Nigeria
In Nigeria, there is a prevalence of aversive life circumstances that frequently assail the mental health and well-being of the citizens, mitigating the impact of which necessitates the institution of psychoth...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:34 -
Linking market authorizations of medicines with disease burden in South Africa
Sub-Saharan Africa is going through an epidemiological transition, including an impressive increase in non-communicable diseases. The introduction of medicines has not kept pace with the needs in developing co...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:33 -
CoViD vaccines and thrombotic events: EMA issued warning to patients and healthcare professionals
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:32 -
Evaluation of drug prescription pattern using World Health Organization prescribing indicators in public health facilities found in Ethiopia: systematic reviews and meta-analysis
Drug use evaluation is a structured, methodological, and criteria-based drug assessment system that helps to evaluate the actual trend of drug use in a particular setting. If drug prescription practices are in...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:31 -
Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?
Advanced therapy medicinal products (ATMPs) represent an important cornerstone for innovation in healthcare. However, uncertainty on the value, the high average cost per patient and their one-shot nature has r...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:30 -
Establishment of the African Medicines Agency: progress, challenges and regulatory readiness
Insufficient access to quality, safe, efficacious and affordable medical products in Africa has posed a significant challenge to public health for decades. In part, this is attributed to weak or absent policie...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:29 -
Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we?
Monitoring adverse drug reactions is a vital issue to ensure drug safety and to protect the general public from medication-related harmful effects. In order to properly monitor drug safety, a regulatory system...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:15 -
Geographical accessibility of medicines: a systematic literature review of pharmacy mapping
Measuring access to medicines has often been limited to assessing availability and affordability, while little is known regarding other dimensions of access including geographical accessibility. Our study aims...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:28 -
History taking and response to an adult diarrheal case among community drug retail outlets in Gondar town, north-west Ethiopia: a simulated-client survey
Self-care is one of the growing tasks of community pharmacy professionals. They are highly engaged in consultations in response to specific drug request (product-based presentation) or symptoms clients describ...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:26
Follow
Annual Journal Metrics
-
Citation Impact
1.411 - Source Normalized Impact per Paper (SNIP)
0.675 - SCImago Journal Rank (SJR)
3.4 - CiteScoreSpeed
28 days to first decision for all manuscripts (Median)
57 days to first decision for reviewed manuscripts only (Median)Usage
688,070 Downloads (2021)
4282 Altmetric mentions (2021)